Bijl M - Search Results

1

Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, Labetoulle M, Michel JP, Naldi L, Sanmarti LS, Weinke T. Johnson RW, et al. Among authors: bijl m. Ther Adv Vaccines. 2015 Jul;3(4):109-20. doi: 10.1177/2051013615599151. Ther Adv Vaccines. 2015. PMID: 26478818 Free PMC article. Review.

2

Immunization of patients with autoimmune inflammatory rheumatic diseases (the EULAR recommendations).

van Assen S, Bijl M. van Assen S, et al. Among authors: bijl m. Lupus. 2012 Feb;21(2):162-7. doi: 10.1177/0961203311429555. Lupus. 2012. PMID: 22235048 Review.

3

Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.

Rondaan C, de Haan A, Horst G, Hempel JC, van Leer C, Bos NA, van Assen S, Bijl M, Westra J. Rondaan C, et al. Among authors: bijl m. Arthritis Rheumatol. 2014 Nov;66(11):3122-8. doi: 10.1002/art.38804. Arthritis Rheumatol. 2014. PMID: 25223407

4

Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma.

Tete SM, Bijl M, Sahota SS, Bos NA. Tete SM, et al. Among authors: bijl m. Front Immunol. 2014 Jun 3;5:257. doi: 10.3389/fimmu.2014.00257. eCollection 2014. Front Immunol. 2014. PMID: 24917865 Free PMC article. Review.

5

Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?

Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG. Bijl M, et al. J Autoimmun. 1998 Oct;11(5):457-63. doi: 10.1006/jaut.1998.0233. J Autoimmun. 1998. PMID: 9802929

6

Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse.

van Lopik T, Bijl M, Hart M, Boeije L, Gesner T, Creasy AA, Kallenberg CG, Aarden LA, Smeenk RJ. van Lopik T, et al. Among authors: bijl m. J Rheumatol. 1999 Jan;26(1):60-7. J Rheumatol. 1999. PMID: 9918241

7

Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes.

Dijstelbloem HM, Bijl M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, Sluiter WJ, Limburg PC, Derksen RH, van de Winkel JG, Kallenberg CG. Dijstelbloem HM, et al. Among authors: bijl m. Arthritis Rheum. 2000 Dec;43(12):2793-800. doi: 10.1002/1529-0131(200012)43:12<2793::AID-ANR20>3.0.CO;2-6. Arthritis Rheum. 2000. PMID: 11145038 Free article.

8

Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).

Bijl M, Horst G, Limburg PC, Kallenberg CG. Bijl M, et al. Clin Exp Immunol. 2001 Jan;123(1):127-32. doi: 10.1046/j.1365-2249.2001.01418.x. Clin Exp Immunol. 2001. PMID: 11168009 Free PMC article.

9

Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.

Bijl M, Horst G, Limburg PC, Kallenberg CG. Bijl M, et al. Ann Rheum Dis. 2001 May;60(5):523-6. doi: 10.1136/ard.60.5.523. Ann Rheum Dis. 2001. PMID: 11302879 Free PMC article.

10

Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes.

Bijl M, Horst G, Limburg PC, Kallenberg CG. Bijl M, et al. Eur J Clin Invest. 2001 Jun;31(6):550-3. doi: 10.1046/j.1365-2362.2001.00842.x. Eur J Clin Invest. 2001. PMID: 11422406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters